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Edited by Maurice MontalAbstract We show that the ﬁve subunits of a c-aminobutyric
acid type A receptor (GABAA receptor) can be concatenated
to yield a functional receptor. This concatenated receptor a1–
b2–a1–c2–b2 has the advantage of a known subunit arrangement.
Most of its functional properties are not signiﬁcantly diﬀerent
from a receptor formed by individual subunits. Extent of expres-
sion amounted to about 40% of that of non-concatenated recep-
tors in Xenopus oocytes, after injection of oocytes with
comparable amounts of cRNA coding for concatenated and
non-concatenated receptors. The ability to express receptors
consisting of ﬁve subunits enables detailed studies of GABAA
receptor subtype selective compounds.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The fast neuronal action of the major inhibitory neurotrans-
mitter c-aminobutyric acid (GABA) is mediated by c-amino-
butyric acid type A receptors (GABAA receptors). They are
integral membrane proteins consisting of ﬁve subunits sur-
rounding a central channel selective for chloride ions [1]. The
major isoforms of the GABAA receptor are composed of two
a, two b and one c subunit(s) [2–6]. cbaba, counter-clockwise
when it viewed from the synaptic cleft, was identiﬁed as the
correct subunit arrangement of the major adult GABAA recep-
tor isoform a1b2c2 [6,7]. Several classes of drugs, including
benzodiazepines, act at GABAA receptors [8,9]. The subunit
composition of a GABAA receptor determines its pharmaco-
logical properties [10].
GABAA receptors formed from concatenated subunits (for
review, see [11]) have been used to study receptor architecture
[6,7], to study positional eﬀects of point mutations [12,13] and
positional eﬀects of subunit isoforms [14,15]. So far GABAA
receptors made of dual and triple subunit constructs have been
reported. Very recently, it has been shown that in the case of
nicotinic acetylcholine receptors all ﬁve subunits may be con-
catenated to give a functional receptor upon expression in
Xenopus oocytes [16]. However, currents could only be shown
after injection of more than 100-fold the usual amount ofAbbreviations: GABA, c-aminobutyric acid; GABAA receptor, c-am-
inobutyric acid type A receptor
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such a concatenated ﬁve subunit construct may be functionally
expressed in Xenopus oocytes after injection with comparable
amounts of cRNA coding for non-concatenated and concate-
nated receptors. As currents mediated by concatenated and
non-concatenated receptors have very similar properties, these
concatenated receptors provide a drug assay system of
GABAA receptors with perfectly deﬁned subunit isoform
composition and positioning.2. Materials and methods
2.1. Construction of the pentameric subunit cDNA
For simplicity, we use in the following a for modiﬁed rat a1, b for rat
b2 and c for rat c2. The modiﬁed rat a subunit diﬀers from the rat a by
one amino acid residue, that confers the subunit speciﬁc bd24 antibody
recognition [17,18] and corresponds to human a1. This property has
previously been used to exclude proteolysis of the linked constructs
[6]. The antibody only reacts if the N-terminal of the a subunit is free.
Tandem constructs with various linker lengths were made as described
in [6,7]. In the following, numbers between two subunit symbols de-
scribe the length of the introduced synthetic linker. The following link-
ers have been introduced: c–26–b: Q5A3PAQ3APA3PA2Q5, a–10–b
and a–10–c: Q10, b–23–a: Q3(Q2A3PA)2AQ5. Triple constructs were
prepared from tandem constructs as exempliﬁed for the b–23–a–10–c
(b–a–c) construct: The b–23–a (b–a) tandem construct was cut by
BamHI in the a subunit and the vector behind the gene to yield a
7 kb fragment containing the sequence of the vector, the b subunit,
the linker and the beginning of the a subunit. This vector fragment
was dephosphorylated with shrimp alkaline phosphatase (USB) in
10 mM Tris–HCl, pH 8.0 and 100 mM MgCl2 for 1 h at 37 C. The
a–10–c (a–c) tandem construct was cut by BamHI in the a subunit
and the vector behind the gene to yield a 2 kb fragment containing
the sequence of the second half of the a subunit, the linker and the c
subunit. The two fragments were ligated and proper ligation was
checked by restriction analysis. The construct a–10–b–23–a–10–c (a–
b–a–c) was made accordingly from a–10–b and b–23–a–10–c using
HindIII to cut in b. The construct a–10–b–23–a–10–c–26–b (a–b–a–
c–b) was made accordingly from a–10–b–23–a–10–c and c–26–b, using
an AgeI restriction site introduced by mutation into the c subunit of
both constructs. After ligation the restriction site was removed again.
2.2. Expression of concatenated subunit constructs in Xenopus oocytes
Capped cRNAs were synthesized (Ambion, Austin, TX) from the
linearized pCMV vectors containing the pentameric construct or the
single a1, b2 and c2 subunits, respectively. A poly-A tail of about
400 residues was added to each transcript using yeast poly-A polymer-
ase (USB, Cleveland, OH). The concentration of the cRNA was quan-
tiﬁed on a formaldehyde gel using Radiant Red stain (Biorad) for
visualization of the RNA and known concentrations of RNA ladder
(Gibco-BRL) as standard on the same gel. cRNAs were precipitated
in ethanol/isoamylalcohol 19:1, the dried pellet dissolved in water
and stored at 80 C. cRNA mixtures were prepared from these stock
solutions and stored at 80 C. Isolation of oocytes from the frogs,blished by Elsevier B.V. All rights reserved.
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done as described earlier [19]. Oocytes were injected with 50 nl of the
cRNA solution. cRNA coding for the pentameric construct was used
at 10 nM concentration. The combination of non-concatenated modi-
ﬁed rat a1, rat b2 and rat c2 subunits was expressed at
10 nM:10 nM:50 nM. As the cRNA for concatenated receptors codes
for two copies of each a1 and b2 subunits and one copy of c2 subunits,
oocytes injected with this cRNA obtained twice the amount of genetic
information coding for a1 and b2 subunits and one ﬁfth of genetic
information coding for the c2 subunit as compared to oocytes injected
with cRNA coding for non-concatenated receptors. The injected oo-
cytes were incubated in modiﬁed Barth’s solution (10 mM HEPES,
pH 7.5, 88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 0.82 mM
MgSO4, 0.34 mM Ca(NO3)2, 0.41 mM CaCl2, 100 U/ml penicillin,
100 lg/ml streptomycin) at 18 C.
2.3. Two-electrode voltage-clamp measurements
All measurements were done in medium containing 90 mM NaCl,
1 mM MgCl2, 1 mM KCl, 1 mM CaCl2 and 5 mM HEPES, pH 7.4
at a holding potential of 80 mV. For the determination of maximal
current amplitudes 1 mM GABA (Fluka, Switzerland) was applied
for 20 s. GABA-evoked currents (at 8–12% of the maximal current
amplitude) were inhibited by varying concentrations of bicuculline
methiodide (RBI) or picrotoxin. Relative current stimulation by diaz-
epam was determined at a GABA concentration evoking 2–5% of the
maximal current amplitude in combination with varying concentra-
tions of diazepam (DZ; Roche, Switzerland) and expressed as
((I(GABA+DZ)/I(GABA))  1) · 100%. Data given in the text are expressed
as mean ± S.D. Data shown in ﬁgures are given as mean ± S.E.M.
2.4. Transient transfection in HEK-293 cells
The cells were maintained in minimum essential medium (Gibco-
BRL) supplemented with 10% fetal calf serum, 2 mM glutamine,
50 U/ml penicillin and 50 lg/ml streptomycin by standard cell culture
techniques. Equal amounts (total of 3 lg DNA/35 mm dish) of plas-
mids coding for GABAA receptor subunits or 1 lg/35 mm dish of pla-
mids coding for a double and a triple construct, or for the pentamer,
were co-transfected with 1 lg/35 mm dish of plasmid coding for the
GFP into human embryonic kidney 293 cells (ATCC no. CRL 1573)
by the calcium phosphate precipitation method [20]. After overnight
incubation, the cells were washed twice with serum free medium and
re-fed with medium.
2.5. Patch-clamp experiments
For whole-cell patch-clamp recordings, electrodes were pulled from
thick-walled borosilicate glass capillaries (GC150F, Harvard appara-
tus, Edenbridge, UK) with DMZ-universal puller (Zeitz-Instrumente,
Augsburg, Germany), ﬁred polished and coated with Sylgard. They
were ﬁlled with an internal solution containing 151 mM KCl, 1 mM
MgCl2, 1 mM CaCl2, 5 mM EGTA, 10 mM HEPES (pH 7.4) and
had resistances of 3–5 MX. The extracellular solution contained
141 mM NaCl, 1 mM CaCl2, 5 mM MgCl2, 10 mM KCl, 10 mM glu-
cose and 10 mM HEPES (pH 7.4). The chloride equilibrium potential
is near 0 mV. Currents were ﬁltered with a 2.9 kHz Bessel ﬁlter and re-
corded using an EPC-10 ampliﬁer interfaced with a G4 Macintosh
computer. The sampling rate was 10 kHz. Data were recorded in par-
allel on a x–y recorder. Voltage commands and current measurements
were performed using Patchmaster software (HEKA, Lambrecht/
Pfalz, Germany). Cells were voltage-clamped at 80 mV and the solu-
tions containing GABA were applied using a rapid perfusion system
consisting of pulled double-barrel glass ﬂow pipes connected to a War-
ner Perfusion Fast-step (Warner Instrument, Hamden, USA). 10–90%
rise-time to peak for currents elicited by GABA was about 20 ms. Dig-
ital data were lost and redrawn from the x–y recorder traces.Fig. 1. Non-concatenated a1/b2/c2 or concatenated a1–b2–a1–c2–b2
GABAA receptors were expressed in Xenopus oocytes. Increasing
concentrations of GABA were applied to the oocytes and the
corresponding current amplitudes determined. Seven individual con-
centration response curves were averaged for non-concatenated
receptors and four for concatenated receptors. Data are expressed as
mean ± S.E.M.3. Results
3.1. Functional expression in Xenopus oocytes
Robust functional expression of the construct was achieved
in Xenopus oocytes. 24 h after microinjection with cRNA
coding for the pentameric a1–b2–a1–c2–b2 GABAA receptorfunctional expression amounted to about 1.5 lA and 48 h after
injection to about 3 lA. This latter value should be compared
with about 5–9 lA obtained with the corresponding receptor
composed of non-concatenated subunits. Functional proper-
ties of concatenated receptors were very similar to those of
non-concatenated receptors. Cumulative concentration re-
sponse curves with the agonist GABA indicated that subunit
concatenation had little eﬀect on agonist parameters with an
EC50 of 73 ± 22 lM (n = 4) and a Hill coeﬃcient of 1.4 ± 0.1
as compared with non-concatenated subunits with an EC50
of 58 ± 24 lM (n = 7) and a Hill coeﬃcient of 1.2 ± 0.1
(Fig. 1). 1 mM pentobarbital elicited by itself currents that
amounted to 27 ± 2% (n = 3) of the maximal current ampli-
tudes elicited by GABA in the same oocytes. This is slightly
lower than the corresponding value of 40 ± 3% (n = 3) in
non-concatenated receptors. Concentration dependent stimu-
lation by diazepam of currents elicited by GABA was also
studied (Fig. 2). Diazepam stimulated non-concatenated and
concatenated receptors with a similar EC50 amounting to
113 ± 18 nM (n = 3) and 81 ± 12 nM (n = 3), respectively.
Maximal stimulation amounted to 200 ± 25% (n = 3) and
247 ± 21% (n = 4), respectively. This diﬀerence did not reach
signiﬁcance levels in this experiment, but a diﬀerence was also
previously noted in receptors made of a dual and a triple sub-
unit construct [7]. This may be due to a contamination with
receptors not containing the c2 subunit in the case of non-con-
catenated receptors [21]. A detailed comparison of the stimula-
tion by diazepam of non-concatenated and concatenated
receptors justifying these conclusions has been presented else-
where [7]. Concentration dependent inhibition of currents elic-
ited by GABA at about EC10 were determined for bicuculline
and picrotoxin. The IC50 for bicuculline was 1.5 ± 0.3 lM
(n = 4) for concatenated and 1.2 ± 0.2 lM (n = 4) for non-con-
catenated receptors (Fig. 3). The IC50 for picrotoxin was
1.9 ± 0.3 lM (n = 4) for concatenated and 2.6 ± 0.8 lM
(n = 3) for non-concatenated receptors (Fig. 4). The reversal
potential of the current elicited by GABA amounted to
Fig. 3. Non-concatenated a1/b2/c2 or concatenated a1–b2–a1–c2–b2
GABAA receptors were expressed in Xenopus oocytes. Increasing
concentrations of bicuculline in combination with 20 lM GABA were
applied to the oocytes and the corresponding current amplitudes
determined. Four individual concentration inhibition curves were
averaged for each, non-concatenated receptors and for concatenated
receptors. Data are expressed as mean ± S.E.M.
Fig. 4. Non-concatenated a1/b2/c2 or concatenated a1–b2–a1–c2–b2
GABAA receptors were expressed in Xenopus oocytes. Increasing
concentrations of picrotoxin in combination with 10 lM GABA were
applied to the oocytes and the corresponding current amplitudes
determined. Four individual concentration inhibition curves were
averaged for each, non-concatenated receptors and for concatenated
receptors. Data are expressed as mean ± S.E.M.
Fig. 2. Non-concatenated a1/b2/c2 or concatenated a1–b2–a1–c2–b2
GABAA receptors were expressed in Xenopus oocytes. Increasing
concentrations of diazepam in combination with 5 lM GABA were
applied to the oocytes and the corresponding current amplitudes
determined. Three individual concentration inhibition curves were
averaged for each, non-concatenated receptors and for concatenated
receptors. Data are expressed as mean ± S.E.M.
Fig. 5. Non-concatenated a1/b2/c2 or concatenated a1–b2–a1–c2–b2
GABAA receptors were expressed in Xenopus oocytes. The time course
of current desensitization was determined by applying 10 mM GABA
during a time period of 5 min.
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concatenated receptors [22]. While so far all the investigated
parameters were very similar in concatenated and non-concat-
enated receptors, some diﬀerences were observed in the desen-
sitization properties. Fig. 5 illustrates the time course of the
current elicited by 10 mM GABA in non-concatenated and
concatenated receptors. The time course of the decay of the
current elicited by 10 mM GABA in concatenated receptors
could be ﬁtted with two exponentials. A ﬁrst component
amounting to 42.5 ± 7.3% was ﬁtted with s = 7.0 ± 1.0 s and
a second component amounting to 57.5 ± 7.3% was ﬁtted with
s = 30.9 ± 3.4 s. The residual non-desensitizing currentamounted to 4.1 ± 0.7% of Imax. This value was similar for
non-concatenated receptors with 5.0 ± 2.0% of Imax. However,
in these receptors decay of the current followed a mono-expo-
nential time course characterized by s = 22.1 ± 4.1 s.
Fig. 6. Concatenated b2–a1–c2/b2–a1 or concatenated a1–b2–a1–c2–b2
GABAA receptors were transiently expressed in HEK-293 cells. Brief
pulses of saturating concentrations of GABA were applied to the cells.
Currents were measured with the whole-cell patch-clamp technique as
described under Section 2.
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Whole-cell patch-clamp experiments were performed 48 h
after transfection. For the non-concatenated subunits a1, b2
and c2, the maximal current amplitude elicited by GABA
was typically 5–10 nA. For receptors consisting of dual and tri-
ple concatenated subunits c2–b2–a1/b2–a1 reduced peak cur-
rent amplitudes were observed, amounting to 0.26 ± 0.17 nA
(n = 6) at 10 lM GABA and 2.2 ± 0.9 nA (n = 6) at 500 lM
GABA. Similar expression levels and a detailed kinetic charac-
terization of these receptors expressed in HEK-293 cells have
been described by Gallagher et al. [23]. An example of a cur-
rent trace recorded after application of 500 lM GABA is
shown in Fig. 6. Pentameric a1–b2–a1–c2–b2GABAA receptors
resulted in a further reduction of currents. Functional expres-
sion amounted to 0.12 ± 0.05 nA (n = 6) as determined at
1 mM GABA (Fig. 6).4. Discussion
We have previously shown [6,7,14,15] that GABAA recep-
tors consisting of dual and triple concatenated subunits result
in receptors with similar properties as receptors composed of
non-concatenated subunits. Here, we extend this approach to
concatenated receptors consisting of a single entity composed
of ﬁve subunits. Most of the studied properties, GABA con-
centration response curve, sensitivity to inhibition by bicucul-
line and picrotoxin and reversal potential, were similar to those
of wild type receptors. One exception is the sensitivity to stim-
ulation by diazepam, that is higher, though not signiﬁcantly, in
concatenated receptors. A likely reason has been discussed in
the result section. A second exception is the desensitization
properties that show small but signiﬁcant alteration. It might
be the case that one or several of the linkers aﬀects the rate
of channel opening or closing.
A major diﬀerence concerns the relative current amplitude in
comparison to non-concatenated receptors. In Xenopus
oocytes, concatenated receptors produce about 40% of thecurrent amplitude detected upon expression of non-concate-
nated receptors, after injection with comparable amounts of
cRNA coding for concatenated receptors as used for non-con-
catenated a and b subunits (0.5 fmol/oocyte). In principle this
reduced amplitude could be due to a decreased single channel
amplitude, to an altered rate of channel opening or closing or
due to an altered eﬃciency of expression. We consider it unli-
kely that the single channel amplitude is aﬀected. Altered ki-
netic properties are also unlikely to be the cause as the
weighted desensitization properties are very similar. Most
probably either the eﬃciency of translation, traﬃcking or sur-
face insertion is reduced in concatenated receptors. This slight
reduction of expression should be compared to the 4–10-fold
reduction after injection with the 100-fold higher amount of
cRNA (about 40 fmol/oocyte) coding for concatenated recep-
tors compared to non-concatenated a and b subunits (about
0.4 fmol/oocyte) in the case of pentameric concatenated nico-
tinic acetylcholine receptors as recently reported [16]. In
HEK-293 cells current amplitudes upon transfection of the
concatenated GABAA receptor are reduced to larger extent.
For discussion we assume here that the same considerations
as in the case of oocytes apply and that this reduction is due
to reduced eﬃciency of expression. Expression level of a con-
catenated receptor consisting of a dual and a triple subunit
construct amounts to about 30% of the receptor composed
of non-concatenated subunits. Concatenation to a pentameric
construct further reduces this number to about 2%. The reason
for this reduction that seems to be cell speciﬁc is not clear.
Evidence has been provided that upon expression of three
subunits a mixture of receptors consisting of three or two sub-
units are formed [21]. Also, positional eﬀects of subunit place-
ment in the receptor pentamer have been observed [14]. Using
concatenated receptors composed of dual and triple subunit
constructs can deal with these complications, but a small resid-
ual uncertainty due to theoretically possible rearrangement of
dual subunit constructs [6] remains. Whether or not this small
uncertainty justiﬁes the extra work linking dual and triple sub-
unit constructs should be left open. It is in any case interesting
that a pentameric construct is functional. The fact that all ﬁve
subunits of a GABAA receptor may be concatenated will allow
detailed studies of GABAA receptor subtype selective com-
pounds.
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